Private Equity Firm Cinven Acquires Mercury Pharma from HgCapital

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 8 (Table of Contents)

Published: 31 Aug-2012

DOI: 10.3833/pdr.v2012.i8.1793     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

European private equity firm Cinven has agreed to acquire the UK-based speciality pharmaceutical company Mercury Pharma for an enterprise value of £465 M (US$730 M) from private equity trust HgCapital...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details